SOURCE: Long Island Capital Alliance

Long Island Capital Alliance

March 04, 2013 09:00 ET

Long Island Capital Alliance Announces Participants for Health Care Capital Forum

Event Held on March 8 in Collaboration With The Center for Advanced Sensor Technologies at Stony Brook University

MELVILLE, NY--(Marketwire - Mar 4, 2013) - The Long Island Capital Alliance ("LICA"), the leading non-profit capital formation and business development organization serving regional companies, today announced the presenting companies and panelists for its Health Care Capital Forum to be held on March 8, 2013. The capital forum will be held in collaboration with The Center for Advanced Sensor Technologies at Stony Brook University.

The presenting companies to be showcased at LICA's Health Care Capital Forum were selected by LICA for this event from a wide selection of developing medical technology, life sciences and health care information technology companies on Long Island and the nearby region. Several of the presenting companies provide best-in-class solutions to enhance medical related diagnostics and therapies as well as health care administration and productivity advancements. These exciting health care companies are in need of private investment and other business development assistance. Each of the companies selected for presentation will provide a discussion of their technology, product or service, a financial overview and catalysts for significant growth. A panel of health care investors will also participate in the event. The panel will provide insights on presenting companies' business plans and investment potential, as well as a review of the current investment climate for health care companies.

Health Care Capital Forum on March 8, 2013 - Participants

Panel of Investors

Larry Chaityn: Larry Chaityn is a Managing Director and Head of Global Health care Banking at Kaminski Partners, a global investment bank. He is responsible for overseeing the day-to-day operations of the bank including deal sourcing, deal review, due diligence investigation and client-facing operations. He has 14 years of health care/life sciences advisory experience, is an active member in the venture capital and angel investment communities and in the National Association of Health Services Executives.

Rusty Ray: Rusty Ray is a partner with 11T Partners, a health care-focused investment bank. He has worked with a wide variety of clients in the health care industry ranging from large pharmaceutical companies to early-stage drug development companies to medical device and service-based companies. Prior to forming 11T Partners, Mr. Ray was a Partner with Brocair Partners, a health care investment banking boutique.

Paul Smolevitz: Paul Smolevitz is a Managing Director and was a founding partner of TM Capital Corp in 1989. Since then, he has led TM Capital's execution of many complex transactions, including financings, strategic acquisitions, restructurings and fairness opinions. Previously, Paul served as a Vice President at Thomson McKinnon Securities Inc. and as a Senior Accountant at Deloitte & Touche. He is a graduate of the Wharton School of the University of Pennsylvania and earned an MBA from the Harvard Business School.

Steve Winick: Steve Winick is a principal of Topspin Partners, one of Long Island's leading venture capital firms. Steve previously served as CIO of Honeywell International's $2B security group. He had been with Honeywell (and the Ademco division of Pittway Corp., before its acquisition by Honeywell in 2000) for over 21 years as CTO of the security business, as well as founder and president of its wireless communications services business.

Presenting Companies

AdhereTech: The company has patented smart pill bottles that increase medication adherence. These bottles measure the exact amount of pills or liquid in the bottle in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via automated phone call or text message. This process increases adherence, leads to reductions in expensive patient procedures and hospital readmissions, and requires zero setup for patients. The open architecture of AdhereTech's technology can integrate with all existing apps, programs, and adherence solutions. Its servers record anonymized, HIPAA-compliant adherence data for patients based on drug, disease state, and demographic.

Wow Factor: AdhereTech has created patented smart pill bottles that increase medication adherence. These bottles measure the exact number of pills or liquid in the bottle in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via phone call or text.

Venus Pharmaceuticals International: Venus Pharmaceuticals is a FDA registered and cGMP compliant nutraceutical manufacturing facility. Based in Hauppauge, NY, the Company specializes in the formulation and production of all major forms of functional foods, and is now expanding into micro-algae based biopharmaceuticals.

Wow Factor: Venus Pharmaceuticals International, Inc., a well-established pharmaceuticals manufacturer, has developed a proprietary photo-bioreactor technology to grow, harvest, and dry/extract micro-algae indoors, which is extremely useful for its medicinal properties.

Mobile Health One: Mobile Health One is a national health care communications technology company founded by respected neurosurgeon and successful entrepreneur John Abrahams, M.D. The Company has developed MDChat, a cloud-based mobile communication system that lets health care providers communicate instantly with one another in a secure environment. MDChat is positioned to provide a new model for workflow productivity in the health care industry. It unifies professionals within and between organizations into a collective communications environment that will ultimately lead to better patient care."

Wow Factor: Mobile Health One, Inc. develops mobile, on-demand HIPAA-compliant systems that unify health care professionals within and between organizations by simplifying communications to accelerate, consolidate, and control information sharing.

First Wave Technologies Inc.: First Wave Technologies is a newly formed technology firm established to assist researchers and corporations advance their technologies to market. However, more importantly than providing "just money", First Wave's model is to provide a complete management team that can partner with researchers to accelerate introduction of ideas into the hands of customers.

Wow Factor: First Wave Technologies is a medical device facilitation business, with two initial products, the First Crush automated pill crusher in order to make them digestible due to the high demand by the growing population of senior citizens; and a respiratory device conversion and amplification technology that turns a ventilator into the equivalent of a $150,000 anesthesia machine.

Raland Therapeutics: Raland Therapeutics transforms novel ideas into innovative devices to provide researchers with powerful tools to translate cellular data to the preclinical phase. Its experience and passion drive the Company to solve complex biomedical problems that ultimately improve patient care. Advancing innovation from the bench to the bedside, Raland understands the science, compliance, and the business of biomedical devices.

Wow Factor: Raland Therapeutics, Inc. has developed diagnostic and therapeutic devices that use implantable biosensors to provide real time, in-vivo monitoring of biological signaling and cellular responses while minimizing animal handling, labor requirements, cell culture/pathologic processing and capital costs.

CytoSorbents Corporation: CytoSorbents Corporation (OTCQB: CTSO) is a critical care focused company using blood purification to treat life-threatening illnesses and to control excessive, potentially deadly inflammation that could otherwise cause the failure of vital organs.

Wow Factor: CytoSorbents has been awarded contracts from both DARPA and the US Army, and continues to invest significantly in its research and development pipeline. One of its most advanced products under development is HemoDefend, a blood purification technology platform for the blood transfusion industry intended to reduce transfusion reactions and improve the safety of "old" blood by removing many substances, such as antibodies, free hemoglobin and inflammatory mediators that can cause potentially serious and sometimes fatal transfusion reactions.

LICA, in collaboration with The Center for Advanced Sensor Technologies at Stony Brook University, will host the Health Care Capital Forum on March 8, 2013 from 8:00 a.m. to 10:30 a.m. at 68 South Service Road, Melville, NY. At the capital forum, the selected health care presenting companies will showcase their technologies, products and services. A panel of investors and industry experts will observe these presentations and provide their insights on the development of the health care industry and its investments prospects. For more information about the event, please contact LICA today or register online.

About the Long Island Capital Alliance:

Since 1984, the Long Island Capital Alliance (www.licapital.org), formerly known as Long Island Venture Group, has been promoting business growth on Long Island. LICA seeks to create a productive and business-friendly environment that will afford area businesses access to the resources necessary to compete successfully in today's markets. LICA serves as a focal point for the exchange of ideas among new and existing business enterprises, successful entrepreneurs, investors, and service providers. Through quarterly capital forums and special meetings, LICA brings together members of the region's business community, and has been recognized as the place to turn to when small businesses need equity, debt, or other financing, or for investors to find an attractive investment opportunity.

LICA's mission is to encourage economic development on Long Island by facilitating capital formation for a broad range of companies in various industries, from early stage to mature middle market closely held and publicly-traded businesses. LICA accomplishes this primarily through education, networking, quarterly capital forums, periodic special educational meetings, and alliances with other regional organizations. LICA brings together members of the region's business community and serves as the finance arm for significant local business and organizations.

For more information on LICA and its next event, please contact LICA today or register online.

About The Center for Advanced Sensor Technologies at Stony Brook University:
The New York State Center for Advanced Sensor Technology at Stony Brook University provides intellectual, logistical, and material resources for the development of new product technologies by facilitating R&D partnerships between New York companies with an in-state footprint and university researchers. The important outcomes are new jobs, new patents, training of students in company product matters, and improved competitiveness for New York State businesses.

Contact Information

  • Contact:
    Jordan Darrow
    Darrow Associates, Inc.
    (631) 367-1866
    Email Contact